Business Wire

Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology Applications Within the Cancer and Cosmetics Markets

BOSTON--(BUSINESS WIRE)--Emulate, Inc., the leading provider of next-generation in vitro models, today announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program.
FierceBiotech

Organ-chip developer Emulate raises $36M in VC funding

Organ-on-a-chip developer Emulate has gathered $36 million in series C financing, and plans to expand its platform to include a wider range of disease models for drug efficacy testing. The ...
FierceBiotech

AstraZeneca teams with Emulate to use organ-on-a-chip tech for R&D

AstraZeneca is partnering with Emulate to incorporate organ-on-a-chip technology into the pharma giant’s R&D program with the aim of accelerating development of the technology within the company. As ...
Business Wire

Organ-On-Chip Global Market 2018 - Emulate, CN-Bio Innovations, InSphero, Mimetas, TissUse, Hrel, and Nortis Dominating the Industry - Research and Markets

DUBLIN--(BUSINESS WIRE)--The "Organ-On-Chip Global Market 2018" report has been added to Research and Markets' offering. The global market for OOCs was valued at $20 million in 2016. It is expected to ...